TOP STORIES

• ORGANIZATION 80 Medical Institutions Submit Comprehensive Agreements on Info Disclosure in Response to JPMA Transparency GLs
  December 4, 2012

• REGULATORY MHLW to Conduct Field Study for Japanese Version of “Compassionate Use” System
  December 3, 2012

• BUSINESS Fast-growing Plavix Could Become Japan’s No. 1 Ethical Drug by Next Year
  December 3, 2012

• BUSINESS CMIC MPSS to Offer Comprehensive Region-Wide CSO Service for Long-Listed Drugs
  November 30, 2012

• REGULATORY FPMAJ Chairman Naito Nudges CSIMC to Discuss Perpetuation of Premiums, Abolishment of Special Price Cuts for Long-Listed Drugs
  November 29, 2012

• ORGANIZATION IGPA Annual Conference to Adopt Kyoto Declaration including Int’l Harmonization on Generic Evaluation Criteria
  November 28, 2012

• BUSINESS Bayer Eyes Sales of €3 Billion in Japan by 2017: Chairman Dekkers
  November 27, 2012

• BUSINESS Health Professionals Voice Concerns over JPMA Transparency Guidelines
  November 26, 2012

• BUSINESS Decline in Sales of Long-listed Drugs Continues with a Double-punch from Generics, NHI Price Reductions
  November 26, 2012

• BUSINESS MSD to Promote Joint Detailing by Sales Units Specialized in Different Therapeutic Fields: Vice Pres. Kotani
  November 22, 2012

• REGULATORY MHLW Set to Clarify Review Procedures for Companion Diagnostics
  November 21, 2012

• REGULATORY GRU to Propose that Welfare Beneficiaries Be Required to Use Generics as a Rule
  November 20, 2012

• BUSINESS Novartis to Revamp Marketing Structure in CNS Field, Shift from SOV
  November 19, 2012

• BUSINESS E Keppra Grabs 20% Share of Domestic Anti-Epileptic Drug Market; Sales Growing Rapidly
  November 19, 2012

• REGULATORY CSIMC Subcommittee Eyes Price Cuts for Long-Listed Drugs with Slow Generic Penetration
  November 16, 2012

• REGULATORY CSIMC OKs Listing for 15 APIs/22 Products; Peak Sales Estimated at 32.6 Billion Yen for Lotriga
  November 15, 2012

• BUSINESS Japan’s 25 Major Drug Makers Log Contrasting Domestic Biz Results on Varying New Product Performances
  November 14, 2012

• REGULATORY Health Coverage for OTC-Like Drugs Up for Review Yet Again
  November 13, 2012

• REGULATORY Zoledronic Acid, Sildenafil Subject to Pilot Study on Generic RMPs
  November 12, 2012

• BUSINESS Time Will Tell Whether Once-monthly Products Ultimately Dominate or Merely Provide Another Option in the BP Market
  November 12, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 226
• 227
• 228
• 229
• 230
• 231
• 232
• 233
• 234
• …
• Next ›
• 最終 »